Skip to main content
. 2016 Oct 4;186(3):373–386. doi: 10.1111/cei.12859

Figure 4.

Figure 4

Augmentation of CD16hi cell percentage and glycosylphosphatidylinositol‐anchored 80 kD protein (GPI‐80)+ coefficient of variation (CV) in CD16hi cell population from metastatic renal cell carcinoma (mRCC) patients. Neutrophil maturation markers [GPI‐80 CV and GPI‐80 mean fluorescence intensity (MFI)] and immunosuppressive molecules {latency‐associated peptide (LAP)‐1 (transforming growth factor (TGF)‐β1] MFI, CellROX MFI and interleukin (IL)‐10+ cells} were measured in CD16hi cell (neutrophilic cell type) populations from the peripheral blood from healthy volunteers and mRCC patients.